Patent directory · USPTO A61K / A61P
Patents matching “regimen”
70 pharma patents match "regimen" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 70 pharmaceutical patents matching "regimen" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 20260060930
New crystalline Forms, new pharmaceutical Composition and Dose Regimen of a Dipeptidyl peptidase I inhibitor for the Treatment of Patients with Bronchiectasis or other DPP-I mediated Diseases
granted -
US 12390463
Dosage forms and regimens for amino acid compounds
granted -
US 12370181
Regimens of estrogen receptor antagonists
granted -
US 12370163
Levodopa dosing regimen
granted -
US 12364683
Non-sedating dexmedetomidine treatment regimens
granted -
US 12343381
Dosage regimen for pegylated interferon
granted -
US 12336980
Dosing regimen for a selective S1P1 receptor agonist
granted -
US 12303482
Levodopa dosing regimen
granted -
US 12303481
Levodopa dosing regimen
granted -
US 12295931
Levodopa dosing regimen
granted -
US 12290566
Dosing regimens and related compositions and methods
granted -
US 12263149
Levodopa dosing regimen
granted -
US 12263148
Levodopa dosing regimen
granted -
US 12213989
Use of maribavir in treatment regimens
granted -
US 12201596
Levodopa dosing regimen
granted -
US 12194079
Therapeutic regimen for the treatment of Fabry using stabilized alpha-galactosidase
granted -
US 12194150
Levodopa dosing regimen
granted -
US 12138247
Non-sedating dexmedetomidine treatment regimens
granted -
US 12109196
Non-sedating dexmedetomidine treatment regimens
granted -
US 12109185
Levodopa dosing regimen
granted -
US 12090140
Non-sedating dexmedetomidine treatment regimens
granted -
US 12029788
Methods for increasing lean body mass with an exercise regimen and a GDF8 inhibitor that is an anti-GDF8 antibody
granted -
US 11998528
Non-sedating dexmedetomidine treatment regimens
granted -
US 11998529
Non-sedating dexmedetomidine treatment regimens
granted